A multicenter population-based experience with abiraterone acetate (AA) in patients with metastatic castration resistant prostate cancer (mCRPC)

被引：2
|
作者：
Clayton, Ravinder
Heng, Daniel Yick Chin
Wu, Jackson S. Y.
Zielinski, Rob
North, Scott A.
Emmenegger, Urban
Hotte, Sebastien J.
Al-Shamsi, Humaid Obaid
Chen, Leo
Eigl, Bernhard J.
机构：
[1] Tom Baker Canc Clin, Calgary, AB, Canada
[2] British Columbia Canc Agcy, Vancouver Canc Ctr, Vancouver, BC V5Z 4E6, Canada
[3] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[4] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[5] Juravinski Canc Ctr, Hamilton, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.113
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
113
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Validation of a prognostic model for metastatic castrate-resistant prostate cancer (mCRPC) patients receiving abiraterone acetate (AA).
    Ravi, Praful Kumar
    Mateo, Joaquin
    Zafeiriou, Zafeiris
    Altavilla, Amelia
    Ferraldeschi, Roberta
    Sideris, Spyridon
    Grist, Emily
    Smith, Alan D.
    Wong, Sophia
    Lorente, David Look
    Bianchini, Diletta
    Attard, Gerhardt
    De Bono, Johann Sebastian
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] PSA response in black and white patients treated with abiraterone acetate (AA) for metastatic castrate resistant prostate cancer (mCRPC).
    Ramalingam, Sundhar
    Humeniuk, Michael Sandon
    Hu, Rachel
    Rasmussen, Julia
    Healy, Patrick
    Wu, Yuan
    Harrison, Michael Roger
    Armstrong, Andrew J.
    George, Daniel J.
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [33] Examining experiences of patients currently being treated with abiraterone acetate (AA) for metastatic castrate resistant prostate cancer (mCRPC)
    Naim, Ahmad Bilal
    Roland, Barbara
    Wyant, Susan
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] Initial experience with abiraterone acetate in patients with castration-resistant prostate cancer
    Beardo-Villar, P.
    Ledo-Cepero, M. J.
    Gavira-Moreno, R.
    Soto-Delgado, M.
    Soto-Vittalba, J.
    Alvarez-Ossorio, J. L.
    Juarez-Soto, A.
    ACTAS UROLOGICAS ESPANOLAS, 2014, 38 (05): : 339 - 345
  • [35] Suppression of testosterone production using abiraterone acetate (AA) with or without androgen deprivation therapy (ADT) in metastatic castration resistant prostate cancer (mCRPC).
    Jha, Gautam Gopalji
    Jeff, Engle
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [36] EXPLORATORY ANALYSIS OF THE SAFETY PROFILE OF ABIRATERONE ACETATE (AA) IN PATIENTS (PTS) RECEIVING CONCOMITANT RADIATION THERAPY IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
    Saad, Fred
    Molina, Arturo
    Li, Justin
    Thian Kheoh
    Scher, Howard I.
    JOURNAL OF UROLOGY, 2012, 187 (04): : E278 - E278
  • [37] Efficacy and safety of abiraterone acetate (AA) in elderly (75 years) chemo-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Smith, M. R.
    Rathkopf, D.
    Mulders, P.
    Carles, J.
    Van Poppel, H.
    Li, J.
    Kheoh, T.
    Griffin, T.
    Molina, A.
    Ryan, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S708 - S708
  • [38] Durable radiologic and clinical disease stability beyond PSA progression in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA)
    Bianchini, Diletta
    Sandhu, Shahneen Kaur
    Cassidy, Amy Mulick
    Zivi, Andrea
    Mezynski, Janusz
    Mukherji, Deborah
    Pezaro, Carmel Jo
    Reid, Alison Helen
    Oommen, Nikhil Babu
    Olmos, David
    Omlin, Aurelius Gabriel
    Sarvadikar, Ajit
    Thompson, Emilda
    Hunt, Joanne
    Sheridan, Elizabeth
    Attard, Gerhardt
    De Bono, Johann Sebastian
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Pharmacokinetics (PK) and safety of ARN-509 with abiraterone acetate (AA) and prednisone (P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Posadas, Edwin M.
    Chit, Kim N.
    de Wit, Ronald
    de Jonge, Maja J. A.
    Attard, Gerhardt
    Friedlander, Terence
    Yu, Margaret
    Hellemans, Peter
    Chien, Caly
    Abrams, Charlene
    Gonzalez, Martha
    Trudel, Geralyn C.
    Chauhan, Vijay
    Saad, Fred
    CANCER RESEARCH, 2015, 75
  • [40] A randomized trial of abiraterone acetate (AA) administered with 1 of 4 glucocorticoid (GC) regimens in metastatic castration-resistant prostate cancer (mCRPC) patients (pts).
    Attard, Gerhardt
    Merseburger, Axel S.
    Sternberg, Cora N.
    Cerbone, Linda
    Recine, Federica
    Jones, Robert J.
    Feyerabend, Susan
    Berruti, Alfredo
    Joniau, Steven
    Schatteman, Peter
    Geczi, Lajos
    Tenke, Peter
    Werbrouck, Patrick
    Lefresne, Florence
    Shelby, Florence Nave
    Lahaye, Marjolein
    Pick, Corinna
    Tombal, Bertrand F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345